Content Details
S. 4355 (IS) - Drug Deal Disclosure Act
- Category
- Bills and Statutes
- Collection
- Congressional Bills
- SuDoc Class Number
- Y 1.6:
Y 1.4/1:
- Congress Number
- 119th Congress
- Congress Session
- 2nd Session
- Last Action Date Listed
- April 21, 2026
- Action
- Mr. Wyden (for himself, Mr. Welch, Ms. Warren, Mr. Gallego, Mr. Merkley, Mr. Luján, Ms. Baldwin, Mr. Whitehouse, Mr. Kelly, Mr. Sanders, Mr. Warner, Ms. Smith, Ms. Hassan, Ms. Cortez Masto, Mr. Bennet, Mr. Warnock, Ms. Hirono, and Ms. Cantwell) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
- Bill Number
- S. 4355
- Bill Version
- Introduced in Senate (IS)
- Short Title
- Drug Deal Disclosure Act
- Full Title
- To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.
- Sponsors
- Ron Wyden(OR)
- Cosponsors
- Peter Welch (VT); Elizabeth Warren (MA); Ruben Gallego (AZ); Jeff Merkley (OR); Ben Ray Lujan (NM); Tammy Baldwin (WI); Sheldon Whitehouse (RI); Mark Kelly (AZ); Bernard Sanders (VT); Mark R. Warner (VA); Tina Smith (MN); Margaret Wood Hassan (NH); Catherine Cortez Masto (NV); Michael F. Bennet (CO); Raphael G. Warnock (GA); Mazie K. Hirono (HI); Maria Cantwell (WA)
- Committees
- Committee on Health, Education, Labor, and Pensions (Standing)
- United States Code Reference
- 42 U.S.C. 1320a-7b, 1395, 1396, 18031 and 247d-6b